Revvity Net Income 2010-2024 | RVTY

Revvity annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Revvity net income for the quarter ending September 30, 2024 was $0.094B, a 893.65% increase year-over-year.
  • Revvity net income for the twelve months ending September 30, 2024 was $0.254B, a 65.74% decline year-over-year.
  • Revvity annual net income for 2023 was $0.693B, a 21.77% increase from 2022.
  • Revvity annual net income for 2022 was $0.569B, a 39.65% decline from 2021.
  • Revvity annual net income for 2021 was $0.943B, a 29.57% increase from 2020.
Revvity Annual Net Income
(Millions of US $)
2023 $693
2022 $569
2021 $943
2020 $728
2019 $228
2018 $238
2017 $293
2016 $234
2015 $212
2014 $158
2013 $167
2012 $70
2011 $8
2010 $391
2009 $82
Revvity Quarterly Net Income
(Millions of US $)
2024-09-30 $94
2024-06-30 $55
2024-03-31 $26
2023-12-31 $79
2023-09-30 $9
2023-06-30 $36
2023-03-31 $569
2022-12-31 $128
2022-09-30 $85
2022-06-30 $179
2022-03-31 $177
2021-12-31 $190
2021-09-30 $128
2021-06-30 $246
2021-03-31 $379
2020-12-31 $380
2020-09-30 $177
2020-06-30 $137
2020-03-31 $34
2019-12-31 $65
2019-09-30 $59
2019-06-30 $69
2019-03-31 $35
2018-12-31 $71
2018-09-30 $77
2018-06-30 $64
2018-03-31 $26
2017-12-31 $-41
2017-09-30 $91
2017-06-30 $204
2017-03-31 $39
2016-12-31 $65
2016-09-30 $58
2016-06-30 $64
2016-03-31 $47
2015-12-31 $68
2015-09-30 $55
2015-06-30 $49
2015-03-31 $40
2014-12-31 $31
2014-09-30 $42
2014-06-30 $50
2014-03-31 $34
2013-12-31 $67
2013-09-30 $40
2013-06-30 $28
2013-03-31 $32
2012-12-31 $-16
2012-09-30 $30
2012-06-30 $34
2012-03-31 $23
2011-12-31 $-84
2011-09-30 $37
2011-06-30 $30
2011-03-31 $25
2010-12-31 $296
2010-09-30 $13
2010-06-30 $58
2010-03-31 $24
2009-12-31 $36
2009-09-30 $14
2009-06-30 $22
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical Services $13.376B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00